Appropriate reference region selection of 18F-florbetaben and 18F-flutemetamol beta-amyloid PET expressed in Centiloid
Open Access
- 11 September 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1), 1-10
- https://doi.org/10.1038/s41598-020-70978-z
Abstract
The Centiloid (CL) is a method for standardizing amyloid beta (Aβ) quantification through different ligands and methods. To find the most appropriate reference region to reduce the variance in the Aβ CL unit between 18F-florbetaben (FBB) and 18F-flutemetamol (FMM), we conducted head-to-head comparisons from 56 participants using the direct comparison of FBB-FMM CL (dcCL) method with four reference regions: cerebellar gray (CG), whole cerebellum (WC), WC with brainstem (WC + B), and pons. The FBB and FMM dcCL units were highly correlated in four reference regions: WC (R2 = 0.97), WC + B (R2 = 0.98), CG (R2 = 0.92), and pons (R2 = 0.98). WC showed the largest effect size in both FBB and FMM. Comparison of the variance of the dcCL values within the young control group showed that with FBB, WC + B had the smallest variance and with FMM, the WC had the smallest variance. Additionally, WC + B showed the smallest absolute difference between FBB and FMM, followed by the WC, pons, and CG. We found that it would be reasonable to use the WC or WC + B as the reference region when converting FBB and FMM SUVRs into dcCL, which can increase the accuracy of standardizing FBB and FMM PET results.Keywords
Funding Information
- Chonnam National University Hospital Biomedical Research Institute (BCRI20012)
- Korean Health Technology R
- National Research Foundation of Korea (NRF) grant funded by the Korean government (NRF-2019R1A5A2027340)
- Research of Korea Centers for Disease Control and Prevention (2018-ER6202-02)
- National Research Council of Science
This publication has 23 references indexed in Scilit:
- Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 studyAlzheimer's & Dementia, 2015
- Measurement of Longitudinal β-Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value RatiosJournal of Nuclear Medicine, 2015
- Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairmentAnnals of Neurology, 2013
- Amyloid-β Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification MethodsJournal of Nuclear Medicine, 2012
- 18F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trialAnnals of Neurology, 2010
- In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)Journal of Nuclear Medicine, 2010
- Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanismThe Lancet Neurology, 2008
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Mild Cognitive ImpairmentArchives of Neurology, 1999
- A nonparametric method for automatic correction of intensity nonuniformity in MRI dataIEEE Transactions on Medical Imaging, 1998